Title:
USE OF N-ACETYL-CYSTEINE IN THE TREATMENT OF ALLERGIC PATHOLOGIES OF THE RESPIRATORY TRACT
Document Type and Number:
WIPO Patent Application WO2001007019
Kind Code:
A3
Abstract:
The use of NAC in the manufacture of topical pharmaceutical compositions for the treatment of allergic pathologies of the respiratory tract, more particularly allergic rhinitis and asthma, is described.
More Like This:
WO/2000/033787 | DEODORANT COSMETIC COMPOSITION |
JP2023517690 | micronized opicapon |
JP5576097 | Airway resistance improvement agent |
Inventors:
SANTANGELO FRANCESCO (IT)
Application Number:
PCT/EP2000/007036
Publication Date:
September 27, 2001
Filing Date:
July 21, 2000
Export Citation:
Assignee:
ZAMBON SPA (IT)
SANTANGELO FRANCESCO (IT)
SANTANGELO FRANCESCO (IT)
International Classes:
A61K31/198; (IPC1-7): A61K31/198; A61P11/00; A61P11/02; A61P11/06
Domestic Patent References:
WO1998048839A1 | 1998-11-05 | |||
WO1998047497A2 | 1998-10-29 | |||
WO1997046243A1 | 1997-12-11 |
Foreign References:
EP0504112A2 | 1992-09-16 | |||
FR2788436A1 | 2000-07-21 |
Other References:
MEIER SYDOW J. ET AL: "[Clinical picture and treatment of exogenously allergic bronchial asthma ]. KLINIK UND THERAPIE DES EXOGEN ALLERGISCHEN ASTHMA BRONCHIALE.", THERAPIEWOCHE, (1975) 25/24 (3368-3379). CODEN: THEWA6, XP000992533
NELEMANS F A: "DRUGS USED IN BRONCHIAL ASTHMA AND COUGH.", DUKES, M. N. G. (ED.). SIDE EFFECTS OF DRUGS ANNUAL, VOL. 6: A WORLDWIDE YEARLY SURVEY OF NEW DATA AND TRENDS. XVIII+478P. EXCERPTA MEDICA: AMSTERDAM, NETHERLANDS;ELSEVIER/NORTH-HOLLAND, INC.: NEW YORK, N.Y., USA (1982) 0 (0), P171-172., XP000992514
KARG F.: "[Courses of treatment of allergic illnesses of the respiratory system of children]. KINDERKUREN BEI ALLERGISCHEN ATEMWEGSERKRANKUNGEN.", ALLERGOLOGIE, (1978) 1/1 (44-49). CODEN: ALLRDI, XP000992555
KROEGEL C (REPRINT) ET AL: "PULMONARY IMMUNE CELLS IN HEALTH AND DISEASE - THE EOSINOPHIL LEUKOCYTE.2.", EUROPEAN RESPIRATORY JOURNAL, (APR 1994) VOL. 7, NO. 4, PP. 743-760. ISSN: 0903-1936., UNIV FREIBURG, DEPT PNEUMOL, MED CLIN, HUGSTETTER STR 55, D-79106 FREIBURG, GERMANY (Reprint);UNIV SOUTHAMPTON, DEPT PHYSIOL & PHARMACOL, SOUTHAMPTON, ENGLAND, XP000992539
VOLKL K.-P. ET AL: "[Treatment of airway diseases with N- acetylcystein. An open therapeutic observational study involving 2,512 patients]. THERAPIE VON ATEMWEGSERKRANKUNGEN MIT N- ACETYLCYSTEIN. EINE OFENE THERAPIEBEOBACHTUNGSSTUDIE AN 2,512 PATIENTEN.", FORTSCHRITTE DER MEDIZIN, (1992) 110/18 (54-60)., XP002165545
YAMASHITA, N. (1) ET AL: "Interleukin (IL)-8 production in eosinophil by the stimulation with granulocyte macrophage-colony stimulating factor (GM-CSF) and tumor necrosis factor (TNF)-alpha and its relationship to NF-kappaB activation.", EUROPEAN RESPIRATORY JOURNAL, (DECEMBER, 1998) VOL. 12, NO. SUPPLEMENT 29 PP. 2S. PRINT. MEETING INFO.: WORLD ASTHMA MEETING BARCELONA, SPAIN DECEMBER 09-13, 1998, XP000997160
DATABASE WPI Week 196800, Derwent World Patents Index; AN 1966-39429f, XP002165546
DE BACKER, W. ET AL: "Sputum ECP levels in COPD patients decrease after treatment with N- acetylcysteine (NAC.", EUROPEAN RESPIRATORY JOURNAL, (SEPT., 1998) VOL. 12, NO. SUPPL. 28, PP. 225S. MEETING INFO.: EUROPEAN RESPIRATORY SOCIETY ANNUAL CONGRESS GENEVA, SWITZERLAND SEPTEMBER 19-23, 1998 THE EUROPEAN RESPIRATORY SOCIETY., XP000997154
NELEMANS F A: "DRUGS USED IN BRONCHIAL ASTHMA AND COUGH.", DUKES, M. N. G. (ED.). SIDE EFFECTS OF DRUGS ANNUAL, VOL. 6: A WORLDWIDE YEARLY SURVEY OF NEW DATA AND TRENDS. XVIII+478P. EXCERPTA MEDICA: AMSTERDAM, NETHERLANDS;ELSEVIER/NORTH-HOLLAND, INC.: NEW YORK, N.Y., USA (1982) 0 (0), P171-172., XP000992514
KARG F.: "[Courses of treatment of allergic illnesses of the respiratory system of children]. KINDERKUREN BEI ALLERGISCHEN ATEMWEGSERKRANKUNGEN.", ALLERGOLOGIE, (1978) 1/1 (44-49). CODEN: ALLRDI, XP000992555
KROEGEL C (REPRINT) ET AL: "PULMONARY IMMUNE CELLS IN HEALTH AND DISEASE - THE EOSINOPHIL LEUKOCYTE.2.", EUROPEAN RESPIRATORY JOURNAL, (APR 1994) VOL. 7, NO. 4, PP. 743-760. ISSN: 0903-1936., UNIV FREIBURG, DEPT PNEUMOL, MED CLIN, HUGSTETTER STR 55, D-79106 FREIBURG, GERMANY (Reprint);UNIV SOUTHAMPTON, DEPT PHYSIOL & PHARMACOL, SOUTHAMPTON, ENGLAND, XP000992539
VOLKL K.-P. ET AL: "[Treatment of airway diseases with N- acetylcystein. An open therapeutic observational study involving 2,512 patients]. THERAPIE VON ATEMWEGSERKRANKUNGEN MIT N- ACETYLCYSTEIN. EINE OFENE THERAPIEBEOBACHTUNGSSTUDIE AN 2,512 PATIENTEN.", FORTSCHRITTE DER MEDIZIN, (1992) 110/18 (54-60)., XP002165545
YAMASHITA, N. (1) ET AL: "Interleukin (IL)-8 production in eosinophil by the stimulation with granulocyte macrophage-colony stimulating factor (GM-CSF) and tumor necrosis factor (TNF)-alpha and its relationship to NF-kappaB activation.", EUROPEAN RESPIRATORY JOURNAL, (DECEMBER, 1998) VOL. 12, NO. SUPPLEMENT 29 PP. 2S. PRINT. MEETING INFO.: WORLD ASTHMA MEETING BARCELONA, SPAIN DECEMBER 09-13, 1998, XP000997160
DATABASE WPI Week 196800, Derwent World Patents Index; AN 1966-39429f, XP002165546
DE BACKER, W. ET AL: "Sputum ECP levels in COPD patients decrease after treatment with N- acetylcysteine (NAC.", EUROPEAN RESPIRATORY JOURNAL, (SEPT., 1998) VOL. 12, NO. SUPPL. 28, PP. 225S. MEETING INFO.: EUROPEAN RESPIRATORY SOCIETY ANNUAL CONGRESS GENEVA, SWITZERLAND SEPTEMBER 19-23, 1998 THE EUROPEAN RESPIRATORY SOCIETY., XP000997154
Download PDF: